You just read:

European Commission Approves Brineura™ (cerliponase alfa), the First Treatment for CLN2 Disease, a Form of Batten Disease and Ultra-Rare Brain Disorder in Children

News provided by

BioMarin Pharmaceutical Inc.

Jun 01, 2017, 08:31 ET